Atypical fractures are often associated with prolonged use of bisphosphonates, medications that are commonly prescribed to prevent bone loss in patients with osteoporosis. These fractures can occur with minimal or no trauma, typically in the subtrochanteric region of the femur, and may be due to an imbalance in bone remodeling processes. Other potential contributing factors include metabolic bone diseases, vitamin D deficiency, and certain genetic predispositions, highlighting the need for thorough clinical evaluation in affected individuals.